Literature DB >> 9111599

Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines.

H E Jones1, C L Eaton, D Barrow, C M Dutkowski, J M Gee, K Griffiths.   

Abstract

BACKGROUND: The role of growth factors in prostate cell growth has been investigated as these peptides may be involved in the autonomous growth of hormone-independent prostate cancer.
METHODS: Responses of neoplastic (PC-3 and CPA) and non-neoplastic (CAPE) prostatic cell lines to epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) were determined using clonogenic and growth curve analysis. The constitutive expression of EGF, TGF-alpha, and TGF-beta 1-3 mRNA was examined using Northern blotting and EGF and TGF-alpha protein levels were determined immunohistochemically.
RESULTS: Growth curve and clonogenic analysis indicated that EGF and TGF-alpha were mitogenic in each cell line. The magnitude of the clonogenic response varied between the cell lines, with CPA cells showing the greatest growth increases. CPA cells also displayed the highest levels of EGF and TGF-alpha mRNA and protein. TGF-beta 1 mRNA was detected in the order of magnitude, PC-3 > CPA > CAPE. Furthermore, PC-3 and CPA cells expressed TGF-beta 3 and TGF-beta 2 transcripts respectively. In each cell line, the expression of any growth factor mRNA was not affected by exogenous EGF.
CONCLUSIONS: The growth responses of the cell lines to EGF and TGF-alpha did not correlate with their constitutive levels of EGF and TGF-alpha mRNA and protein, thus whilst growth factors may be important in malignant cell growth, other pathways may also be involved in the autocrine regulation of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9111599     DOI: 10.1002/(sici)1097-0045(19970301)30:4<219::aid-pros1>3.0.co;2-g

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  4 in total

1.  Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition.

Authors:  Jubilee R Stewart; Catherine A O'Brian
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

2.  NPM1 silencing reduces tumour growth and MAPK signalling in prostate cancer cells.

Authors:  Gaëlle Loubeau; Rafik Boudra; Sabrina Maquaire; Corinne Lours-Calet; Claude Beaudoin; Pierre Verrelle; Laurent Morel
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

3.  Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3M cells: involvement of voltage-gated sodium channel.

Authors:  Pinar Uysal-Onganer; Mustafa Ba Djamgoz
Journal:  Mol Cancer       Date:  2007-11-24       Impact factor: 27.401

4.  Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells.

Authors:  Lutz Konrad; Jonas A Scheiber; Elke Völck-Badouin; Marcel M Keilani; Leslie Laible; Heidrun Brandt; Ansgar Schmidt; Gerhard Aumüller; Rainer Hofmann
Journal:  BMC Genomics       Date:  2007-09-11       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.